Non ci sono recensioni
The Clinical Translation of Intravenous Immunoglobulin from Substitution to Immunomodulation
Pages 1-11
This practical manual, written by well-known experts, reviews current indications for the use of IgG concentrates and some other modern immunomodulators and provides fundamental information on present-day immunomodulation in patients (and mice). The book opens by tracing the transition from IgG substitution to IgG immunomodulation and providing expert updates on immunomodulatory indications in autoimmune and inflammatory disorders, including hematologic, neurologic, dermatologic, and other diseases. Basic aspects of IgG concentrates, including methods of production, safety, currently available products, and mechanisms of action, are then discussed. An entire chapter is devoted to the different aspects of immunomodulatory IgG treatment in the bleeding disorder immune thrombocytopenia (ITP). Finally, the transition from polyclonal to monoclonal antibody (mAb) treatment is addressed in detail, covering mAb development, methods, mechanisms of action, adverse effects, and more. Particular attention is paid to the example of anti-CD20 (B-cell) antibody.
The Clinical Translation of Intravenous Immunoglobulin from Substitution to Immunomodulation
Pages 1-11
From Immune Substitution to Immuno-modulation
Pages 15-22
Manual of Primary and Secondary Immunodeficiencies
Pages 23-33
Manual of Intravenous and Subcutaneous IgG Indications in Autoimmune Diseases
Pages 35-60
Anti-D: A Type of IVIg
Pages 61-71
Mechanisms of Action and Immunomodulation by IVIg
Pages 73-83
Immunomodulatory Drugs and Monoclonal Antibodies
Pages 85-100
Use of Intravenous Immunoglobulin in Neurology
Pages 101-109
Use of Intravenous Immunoglobulin in Dermatology
Pages 111-118
Historical Aspects of Polyclonal IgG Preparations
Pages 121-132
Basics of Immunoglobulins as Effector Molecules and Drugs
Pages 133-150
Essentials of the Production of Safe and Efficacious State-of-the-Art Polyclonal IgG Concentrates
Pages 151-173
Current IgG Products and Future Perspectives
Pages 175-202
Updates in Immune Thrombocytopenia: Terminology, Immunomodulation and Platelet Stimulation, and Clinical Guidelines and Management
Pages 205-212
Health-Related Quality of Life in Patients with Immune Thrombocytopenia
Pages 213-222
ITP in Childhood: Predictors of Disease Duration
Pages 223-239
Immune Functions of Platelets
Pages 241-259
Thrombopoietin Receptor Agonists: Characteristics, Adverse Effects, and Indications
Pages 261-276
Registries in Immune Thrombocytopenia: The History of the Intercontinental Cooperative ITP Study Group
Pages 277-287
Therapeutic Monoclonal Antibodies as Immunomodulators and Anti-Cancer Agents: Development, Evidence of Efficacy, Mechanisms of Actions, Adverse Effects
Pages 291-341
Monoclonal Anti-CD20 (B-Cell) Antibody and Autoimmune Diseases
Pages 343-363
Sei sicuro di voler eseguire questa azione?